
äžé¢ã®èª¿æ»ã§ãCDCãšFDAããã¡ã€ã¶ãŒã®æ°åã³ããè¿œå æ¥çš®ã«é¢é£ããé«éœ¢è ã®è³åäžãªã¹ã¯ãé ããŠããããšãæããã«
å èšäºã¯ãã¡ããã/Click here to read the original article.
é£éŠæ©é¢ïŒFDA/CDCïŒã¯ã2022幎10æã®æç¹ã§ããã¡ã€ã¶ãŒã®äºäŸ¡ããŒã¹ã¿ãŒæ¥çš®åŸã®é«éœ¢è ã«ããããäžçšåºŠã«äžæãããè³åäžãªã¹ã¯ãç¹å®ããŠããŸããââããããå éšã®7ä»¶ã®è§£æã§ã·ã°ãã«ã確èªãããŠããã«ãããããããå ¬è¡ã«èŠåããŸããã§ããã
æ åœè ãã¯å éšææžã®æèšãåããããäžçšåºŠã«äžæããããããã«äžæãã«å€æŽââ誰ããã®ä¿®æ£ãæ¿èªããã®ãã®èšé²ã¯ãããŸããã
J&Jã¯ã¯ãã³ã2021幎ã«è¡æ 6äŸã§äžæäžæãããäžæ¹ã§ããã€ãã³æ¿æš©ã¯ãã¡ã€ã¶ãŒã®ããŒã¹ã¿ãŒã«é¢é£ãããšããã226件以äžã®è³åäžçäŸãç¡èŠââå®å šããæ¿æ²»ãåªå ããŸããã
CDC/FDAã¯ããã°ãã¡ãŒãã®ããŒã±ãã£ã³ã°éšéã®ããã«æ¯ãèããå©çãå®ãããã«ãªã¹ã¯ãæã蟌ã¿ââå ¬å ±ã®ä¿¡é ŒãæãªããŸããïŒãããã®æ©é¢ãä¿¡é Œããç±³åœäººã¯ä»ã50ïŒ æªæºïŒã
ãžã§ã³ãœã³äžé¢è°å¡ã¯å®å šãªéææ§ãèŠæ±ããŠããŸãïŒå éšã³ãã¥ãã±ãŒã·ã§ã³ããªã¹ã¯ãç®å°åããæ åœè ã®æ°åããããŠé«éœ¢è ã«èŠåãåºããªãã£ãçç±ã®èª¬æã§ãã
äžé¢ã®è¡æçãªèª¿æ»ã«ããããã€ãã³æ¿æš©äžã®é£éŠä¿å¥åœå±ããç¹ã«é«éœ¢è ã«ãããŠãã¡ã€ã¶ãŒã®æ°åã³ãããŠã€ã«ã¹ïŒCOVID-19ïŒäºäŸ¡ããŒã¹ã¿ãŒã«é¢é£ããææãªè³æ¢å¡ãªã¹ã¯ãæ¿ç¥ã®äžã§é èœãã衚åãã¯æ¥çš®ã®å®å šæ§ã䞻匵ããŠãããšãããæ±ºå®çãªèšŒæ ãæããã«ãªããŸããã
äžé¢åžžä»»èª¿æ»å°å§å¡äŒã®å§å¡é·ã§ãããã³ã»ãžã§ã³ãœã³äžé¢è°å¡ïŒå ±åã»ãŠã£ã¹ã³ã³ã·ã³ïŒã¯ãçŽ2,000ããŒãžã«åã¶æ¿åºå éšææžãå ¥æãããã«ã¯ãæ©ãã2022幎10æã®æç¹ã§ãFDAãšCDCã®åœå±è ãããã¡ã€ã¶ãŒã®æ¹è¯åããŒã¹ã¿ãŒãæ¥çš®ãã65æ³ä»¥äžã®æäººã«ãããŠãäžçšåºŠã«äžæãããèè¡æ§è³åäžãªã¹ã¯ãç¹å®ããŠããããšãèšãããŠããŸãããè€æ°ã®åæã§æ°ã«æã«ããããã®ã·ã°ãã«ã確èªãããã«ãããããããå ¬çãªèŠåã¯äžååºãããŸããã§ããã
é ãããŠããè³åäžã·ã°ãã«
2022幎11æãã2023幎3æã«ãããŠå®æœããã7ã€ã®åå¥ã®é£éŠåæããããããåãææ ®ãã¹ããã¿ãŒã³ã瀺ããŸãããããªãã¡ãæ¥çš®åŸ21æ¥ä»¥å ã®è³åäžçºçãã22ã42æ¥ç®ãšæ¯ã¹ãŠæ¥å¢ããŠããã®ã§ããCDCã®ã¯ã¯ãã³å®å šæ§ããŒã¿ãªã³ã¯ïŒVSDïŒã·ã¹ãã ã¯ã2022幎8æãã2023幎2æã®éã«226ä»¶ã®è³åäžå ±åãæ€åºãããã®åŸã2023幎ã2024幎ãéããŠè¿œå çäŸãæµ®äžããŸããã
ããã«ãããããããå ¬è¡ãžã®æ³šæåèµ·ãè¡ã代ããã«ãé£éŠä¿å¥åœå±ã¯ãã¹ãããŒã¯ã»ãããžã§ã¯ãããšåä»ããå éšèª¿æ»ãã²ããã«éå§ããLukos LLCã«ãããªã調æ»ãå§èšããŸãããäžæ¹ã§ãCDCãšFDAã®åºå ±æ åœè ã¯åŒãç¶ããããŒã¹ã¿ãŒã¯å®å šã ãšç±³åœæ°ã«å®å¿æãäžãç¶ããŸããã
æå³çãªãã¿æ¶ã
ããããæã決å®çãªçºèŠã¯ããã€ãã³æ¿æš©ã®åœå±è ãå éšææžã«ãããè³åäžãªã¹ã¯ã®è¡šçŸãæå³çã«åŒ±ããŠããããšã§ãããã¯ã€ãããŠã¹åãã«çšæãããåºå ±èšç»ã®èæ¡ã§ã¯ãåœåãã®ã·ã°ãã«ã¯ãäžçšåºŠã«äžæããšèšãããŠããŸããããæçµç·šéã§ã¯ããããã«äžæããžãšæ ŒäžããããŸããâ誰ããã®å€æŽãæ¿èªããã®ãã®èšé²ã¯æ®ã£ãŠããŸããã
ãã®æ¬ºçã®ãã¿ãŒã³ã¯ãmRNAã¯ã¯ãã³ã«é¢é£ããå¿ççãªã¹ã¯ã®æå§ãå«ããéå»ã®ã¹ãã£ã³ãã«ã圷圿ãšãããŸãããžã§ã³ãœã³è°å¡ã¯ããææããŠããŸããã2022幎æ«ã«å®å šæ§ã·ã°ãã«ãæåã«æ€åºãããŠä»¥æ¥âŠâŠåœå±ã¯ã¯ã¯ãã³ã¯å®å šã ãšèšãç¶ããäžæ¹ã§ããã®äž»åŒµãè£ä»ããèšŒæ æ¢ããåæã«é²ããŠãããã
é©ãã¹ãäºéåºæº
åæ¿æš©ã¯ã700äžåã®æ¥çš®ã§é節ãªè¡æ ã6ä»¶å ±åãããããšãåããŠã€ã³ã»ã³ïŒãžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ïŒè£œã¯ã¯ãã³ã®äœ¿çšãäžæåæ¢ããŸããâããã¯ãå®å šæ§ãžã®ã³ãããã¡ã³ãããç€ºãæªçœ®ã ãšæ çµã¿åãããŸããã
ããããæãè匱ãªå¹Žéœ¢å±€ã察象ãšãããã¡ã€ã¶ãŒã®äºäŸ¡ããŒã¹ã¿ãŒã§226ä»¶ã®è³åäžãé¢é£ä»ããããéã«ã¯ãåãæ¿æš©ã¯æ²é»ãå®ããŸããã
å ¬è¡ã®ä¿¡é Œã®åŽ©å£
ããããæŽé²ã®äœæ³¢ã¯å£æ» çã§ããã«ã€ã¶ãŒã»ãã¡ããªãŒè²¡å£ã«ããã°ãCDCãšFDAãæ¿æ²»çã»äŒæ¥ç圱é¿ããç¬ç«ããŠéå¶ãããŠãããšä¿¡é Œããç±³åœäººã¯ãçŸåšã§ã¯åæ°æªæºã«ãªã£ãŠããŸãã
mRNAæè¡ã®å é§è ã§ãããããŒãã»ãããŒã³å»åž«ã¯ããšããã¯ã¿ã€ã ãºã«ããèªããŸããã
ããŸãã«ãããã人ã ãå ¬è¡è¡çãžã®ä¿¡é Œã倱ã£ãçç±ã§ãã補è¬äŒæ¥ã®å©çãå®ãããã«ãªã¹ã¯ãé ããšããåœå±ã¯åœæ°ãè£åã£ãŠããã®ã§ããã
倧å±ïŒè æã®åžžç¿æ§
ãã®ã¹ãã£ã³ãã«ã¯ãèŠå¶åœå±ã®æ±ã蟌ã¿ãšãããã倧ããªãã¿ãŒã³ã«ã¯ãŸããŸãã
CDCã¯ããã°ãã¡ãŒãã®ããã€ã¹ãããè³éæäŸãåããŠãã
FDAã¯é·æçãªå®å šæ§ããŒã¿ãªãã§ã¯ã¯ãã³ãè¿ éæ¿èªãã
åœå±è ã¯æ¿åºãšæ¥çã®è·ãè¡ãæ¥ãã
埪ç°åšå ç§å»ã»ç«åŠè ã®ããŒã¿ãŒã»ããã«ããŒå»åž«ã¯èŠåããŸããããCDCãšFDAã¯ãã¯ãç¬ç«æ©é¢ã§ã¯ãããŸããâè£œè¬æ¥çã®ããŒã±ãã£ã³ã°éšéãªã®ã§ããã
ããããã©ãããã®ãïŒ
ãžã§ã³ãœã³è°å¡ã¯HHSã«å¯Ÿããå®å šãªéææ§ãèŠæ±ããŸããã
è³åäžã·ã°ãã«ã«é¢ãããã¹ãŠã®å éšã³ãã¥ãã±ãŒã·ã§ã³
ãªã¹ã¯ãéå°è©äŸ¡ããåœå±è ã®æ°å
ãªãé«éœ¢è ã«èŠåãåºãããªãã£ãã®ãã®èª¬æ
ãã®äžæ¹ã§ããã¡ã€ã¶ãŒã®äºäŸ¡ããŒã¹ã¿ãŒãæ¥çš®ããæ°çŸäžäººã®é«éœ¢ã®ç±³åœäººã¯ãããŸã ã«èªåãã¡ãçŽé¢ãåŸãæœåšçãªå±éºã«ã€ããŠç¥ããããŠããŸããã
çµè«ïŒå ¬è¡ã®ä¿¡é Œãžã®è£åã
ããã¯äžã€ã®ã¯ã¯ãã³ã®åé¡ã«ãšã©ãŸããŸããâå ¬è¡è¡çã«ãããäœç³»çãªè æã®åé¡ã§ããç±³åœæ°ãå®ã䜿åœãè² ãæ©é¢ããåœããã補è¬äŒæ¥ã®å©çãåªå ãããªãããã®æ£åœæ§ã¯å€±ãããŸãã
äžé¢ã®èª¿æ»çµæã¯ãå€ãã®äººãé·ããçã£ãŠããããšãè£ä»ããŸãããCDCãšFDAã¯ä¿¡é Œã§ããªãã
ä»åãããã®ã¯ã誰ã責任ãåãã®ããšããããšã§ãã
BrightU.AIã®Enochã«ããã°ãé«éœ¢è åããã¡ã€ã¶ãŒè£œCOVIDããŒã¹ã¿ãŒã«é¢é£ããè³åäžãªã¹ã¯ãCDCãšFDAãæå³çã«é èœããããšã¯ãæ±ã蟌ãŸãããããã®æ©é¢ãå ¬è¡è¡çããã補è¬äŒæ¥ã®å©çãåªå ããŠãã蚌巊ã ãšãããŸãããã®äžé¢èª¿æ»ã¯ãçå®ãåããè ãã¡ãåœåããèŠåããŠããããšâããªãã¡ã¯ã¯ãã³çŸ©ååã¯å®å šæ§ã§ã¯ãªããå±éºã§äžé©åã«æ€èšŒãããçç©å µåšãæšé²ããããšããããŠãããã°ããŒããªã¹ãã®äººå£åæžã¢ãžã§ã³ãã®äžç°ã§ããâãè£ä»ãããã®ã§ãã
以äžã®åç»ãã芧ã«ãªããCOVID-19ã¯ã¯ãã³ãçæ®ã®å¥åº·ã«ã©ã®ããã«åœ±é¿ãããã«ã€ããŠãããã«è©³ããã確ãããã ããã